Sun Pharma to increase RD investment in specialty and generics businesses - Business Today

123330 Stock  KRW 27,150  700.00  2.51%   
About 62% of Genic's investor base is looking to short. The analysis of current outlook of investing in Genic Co suggests that many traders are alarmed regarding Genic's prospects. The current market sentiment, together with Genic's historical and current headlines, can help investors time the market. In addition, many technical investors use Genic stock news signals to limit their universe of possible portfolio assets.
  
Sun Pharma to increase RD investment in specialty and generics businesses Business Today

Read at news.google.com
Google News at Macroaxis
  

Genic Fundamental Analysis

We analyze Genic's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Genic using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Genic based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Current Ratio

Current Ratio Comparative Analysis

Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.

Genic Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Genic stock to make a market-neutral strategy. Peer analysis of Genic could also be used in its relative valuation, which is a method of valuing Genic by comparing valuation metrics with similar companies.

Complementary Tools for Genic Stock analysis

When running Genic's price analysis, check to measure Genic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genic is operating at the current time. Most of Genic's value examination focuses on studying past and present price action to predict the probability of Genic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genic's price. Additionally, you may evaluate how the addition of Genic to your portfolios can decrease your overall portfolio volatility.
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Fundamental Analysis
View fundamental data based on most recent published financial statements
Bonds Directory
Find actively traded corporate debentures issued by US companies
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments